Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio.
Gosselt HR, Verhoeven MMA, de Rotte MCFJ, Pluijm SMF, Muller IB, Jansen G, Tekstra J, Bulatović-Ćalasan M, Heil SG, Lafeber FPJG, Hazes JMW, de Jonge R. Gosselt HR, et al. Among authors: muller ib. Rheumatol Ther. 2020 Dec;7(4):837-850. doi: 10.1007/s40744-020-00230-7. Epub 2020 Sep 14. Rheumatol Ther. 2020. PMID: 32926395 Free PMC article.
Development and Validation of a Sensitive UHPLC-MS/MS-Based Method for the Analysis of Folylpolyglutamate Synthetase Enzymatic Activity in Peripheral Blood Mononuclear Cells: Application in Rheumatoid Arthritis and Leukemia Patients.
Muller IB, Lin M, Struys EA, Heydari P, Hebing RCF, Nurmohamed MT, van der Laken C, Lems WF, Cloos J, Jansen G, de Jonge R. Muller IB, et al. Ther Drug Monit. 2019 Oct;41(5):598-606. doi: 10.1097/FTD.0000000000000638. Ther Drug Monit. 2019. PMID: 31008996
Correction: Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia.
Driehuis E, Oosterom N, Heil SG, Muller IB, Lin M, Kolders S, Jansen G, de Jonge R, Pieters R, Clevers H, van den Heuvel-Eibrink MM. Driehuis E, et al. Among authors: muller ib. PLoS One. 2020 Aug 5;15(8):e0237488. doi: 10.1371/journal.pone.0237488. eCollection 2020. PLoS One. 2020. PMID: 32756611 Free PMC article.
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis.
Fuentelsaz-Romero S, Barrio-Alonso C, García Campos R, Torres Torresano M, Muller IB, Triguero-Martínez A, Nuño L, Villalba A, García-Vicuña R, Jansen G, Miranda-Carús ME, González-Álvaro I, Puig-Kröger A. Fuentelsaz-Romero S, et al. Among authors: muller ib. Front Immunol. 2021 Nov 5;12:776879. doi: 10.3389/fimmu.2021.776879. eCollection 2021. Front Immunol. 2021. PMID: 34804067 Free PMC article.
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial.
Hebing RC, Lin M, Bulatovic Calasan M, Muller IB, Mahmoud S, Heil S, Struys EA, van den Bemt BJ, Twisk JW, Lems W, Nurmohamed MT, Jansen G, de Jonge R. Hebing RC, et al. Among authors: muller ib. Ann Rheum Dis. 2023 Apr;82(4):460-467. doi: 10.1136/ard-2022-223398. Epub 2022 Dec 21. Ann Rheum Dis. 2023. PMID: 36543526 Clinical Trial.
76 results